Hyaluronic acid derivatives
US-9301972-B2 · Apr 5, 2016 · US
Peptides and compositions for treatment of joint damage
US9745358B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9745358-B2 |
| Application number | US-201615212702-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 18, 2016 |
| Priority date | Mar 8, 2013 |
| Publication date | Aug 29, 2017 |
| Grant date | Aug 29, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides new protease resistant polypeptides, as well as compositions and methods for treating, ameliorating or preventing conditions related to joint damage, including acute joint injury and arthritis.
First claim
Opening claim text (preview).
What is claimed is: 1. An isolated polypeptide comprising SEQ ID NO: 28. 2. A pharmaceutical composition comprising the isolated polypeptide of claim 1 . 3. The pharmaceutical composition of claim 2 further comprising a buffer. 4. The pharmaceutical composition of claim 2 further comprising sucrose. 5. The pharmaceutical composition of claim 2 , wherein the composition comprises sucrose and a buffer. 6. An isolated polypeptide consisting of SEQ ID NO: 28. 7. A pharmaceutical composition comprising the isolated polypeptide of claim 6 . 8. The pharmaceutical composition of claim 7 further comprising a buffer. 9. The pharmaceutical composition of claim 7 further comprising sucrose. 10. The pharmaceutical composition of claim 7 , wherein the composition comprises sucrose and a buffer.
Assignees
Inventors
Classifications
for joint disorders, e.g. arthritis, arthrosis · CPC title
Angiogenesic factors; Angiogenin · CPC title
- A61K45/06Primary
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
- C07K14/515Primary
Angiogenesic factors; Angiogenin · CPC title
Transferases (2) · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9745358B2 cover?
- The present invention provides new protease resistant polypeptides, as well as compositions and methods for treating, ameliorating or preventing conditions related to joint damage, including acute joint injury and arthritis.
- Who is the assignee on this patent?
- Novartis Ag
- What technology area does this patent fall under?
- Primary CPC classification A61K45/06. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).